# US 2003/0229453 A1 · Crystals and structures of PAK4KD kinase PAK4KD

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0229453 A1
- Document ID: US20030229453A1
- Status: Published application
- Kind: A1
- Application number: 10/406,676
- Filed: 2003-04-02
- Published: 2003-12-11
- Earliest claimed: 2002-04-09
- Inventors: Stephen Suresh Antonysamy; Ingeborg K. Feil; Sean Grant Buchanan; Kai W. Post; Yi Liu; David Lorber
- Web page: https://patentgrep.com/patent/US20030229453A1

## CPC

- G16B 15/30: Drug targeting using structural data; Docking or binding prediction
- G01N 33/6803: {General methods of protein analysis not limited to specific proteins or families of proteins}
- G16B 15/00: ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
- C07K 2299/00: Coordinates from 3D structures of peptides, e.g. proteins or enzymes
- G01N 2333/91215: with a definite EC number (2.7.1.-)
- G01N 2500/00: Screening for compounds of potential therapeutic value
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention provides machine readable media embedded with the three-dimensional molecular structure coordinates of PAK4KD kinase, and subsets thereof, including binding pockets, methods of using the structure to identify and design affecters, including inhibitors and activator, mutants of PAK4KD, PAK4KD crystals, and compounds and compositions that affect PAK4KD activity.

## Claims

### Claim 1

A method of producing a computer readable database comprising the three-dimensional molecular structural coordinates of a binding pocket of a PAK4KD protein, said method comprising
a) obtaining three-dimensional structural coordinates defining said protein or a binding pocket of said protein, from a crystal of said protein; and
b) introducing said structural coordinates into a computer to produce a database containing the molecular structural coordinates of said protein or said binding pocket.

### Claim 2 (depends on 1)

A method comprising electronic transmission of all or part of the computer readable database produced by claim 1.

### Claim 3 (depends on 1)

A method of producing a computer readable database comprising a representation of a compound capable of binding a binding pocket of a PAK4KD protein, said method comprising
a) introducing into a computer program a computer readable database produced by claim 1;
b) generating a three-dimensional representation of a binding pocket of said PAK4KD protein in said computer program;
c) superimposing a three-dimensional model of at least one binding test compound on said representation of the binding pocket;
d) assessing whether said test compound model fits spatially into the binding pocket of said PAK4KD protein; and
e) storing a representation of a compound that fits into the binding pocket into a computer readable database.

### Claim 4 (depends on 3)

The method of claim 3 further comprising
f) preparing a binding test compound represented in said computer readable database;
g) contacting said compound in a binding assay with a protein comprising said PAK4KD protein binding pocket;
h) determining whether said test compound binds to said protein in said assay; and
i) introducing a representation of a compound that binds to said protein in said assay into a computer readable database.

### Claim 5 (depends on 3)

A method of producing a computer readable database comprising a representation of a binding pocket of a PAK4KD protein in a co-crystal with a compound, said method comprising
a) preparing a binding test compound represented in a computer readable database produced by claim 3;
b) forming a co-crystal of said compound with a protein comprising a binding pocket of a PAK4KD protein;
c) obtaining the structural coordinates of said binding pocket in said co-crystal; and
d) introducing the structural coordinates of said binding pocket or said co-crystal into a computer-readable database.

### Claim 6 (depends on 3)

A method comprising electronic transmission of all or part of the computer readable database produced by claim 3.

### Claim 7 (depends on 3)

A method of modulating PAK4KD protein activity comprising contacting said PAK4KD with a compound, wherein said compound is represented in a database produced by the method of claim 3.

### Claim 8 (depends on 1)

A method of producing a computer readable database comprising a representation of a compound rationally designed to be capable of binding a binding pocket of a PAK4KD protein, said method comprising
a) introducing into a computer program a computer readable database produced by claim 1;
b) generating a three-dimensional representation of the protein or a binding pocket of said PAK4KD protein in said computer program;
c) designing a three-dimensional model of a compound that forms non-covalent bonds with amino acids of a binding pocket of said representation; and
d) storing a representation of said compound into a computer readable database.

### Claim 9 (depends on 8)

The method of claim 8 further comprising
e) preparing a binding test compound comprising a three-dimensional molecular structure represented by the coordinates contained in said computer readable database;
f) contacting said compound in a binding assay with a protein comprising said binding pocket of a PAK4KD protein;
g) determining whether said test compound binds to said protein in said assay; and
h) introducing a representation of a compound that binds to said protein in said assay into a computer-readable database.

### Claim 10

A method of producing a computer readable database comprising structural information about a molecule or a molecular complex of unknown structure comprising:
a) generating an x-ray diffraction pattern from a crystallized form of said molecule or molecular complex;
b) using a molecular replacement method to interpret the structure of said molecule; wherein said molecular replacement method uses the structural coordinates of FIGS. 4-10, or a subset thereof comprising a binding pocket, the structural coordinates of a binding pocket of FIGS. 4-10, or structural coordinates having a root mean square deviation for the alpha-carbon atoms of said structural coordinates of less than 2.0 Å; and
c) storing the coordinates of the resulting structure in a computer readable database.

### Claim 11

A method for homology modeling the structure of a PAK4KD protein homolog comprising:
a) aligning the amino acid sequence of a PAK4KD protein homolog with an amino acid sequence of PAK4KD protein;
b) incorporating the sequence of the PAK4KD protein homolog into a model of the structure of PAK4KD protein, wherein said model has the same structural coordinates as the structural coordinates of FIGS. 4-10, or wherein the structural coordinates of said model's alpha-carbon atoms have a root mean square deviation from the structural coordinates of FIGS. 4-10, of less than 2.0 Å to yield a preliminary model of said homolog;
c) subjecting the preliminary model to energy minimization to yield an energy minimized model; and
d) remodeling regions of the energy minimized model where stereochemistry restraints are violated to yield a final model of said homolog.

### Claim 12

A method for identifying a compound that binds PAK4KD protein comprising:
a) providing a computer modeling program with a set of structural coordinates or a three dimensional conformation for a molecule that comprises a binding pocket of PAK4KD protein, or a homolog thereof;
b) providing a said computer modeling program with a set of structural coordinates of a chemical entity;
c) using said computer modeling program to evaluate the potential binding or interfering interactions between the chemical entity and said binding pocket; and
d) determining whether said chemical entity potentially binds to or interferes with said protein or homolog.

### Claim 13 (depends on 12)

The method of claim 12 further comprising the steps of:
e) computationally modifying the structural coordinates or three dimensional conformation of said chemical entity to improve the likelihood of binding to said binding pocket; and
b) determining whether said modified chemical entity potentially binds to or interferes with said protein or homolog.

### Claim 14

A PAK4KD protein, or a functional PAK4KD protein subunit, or a PAK4KD co-complex in crystalline form.

### Claim 15 (depends on 14)

The crystalline protein, sub unit, or co-complex of claim 14, which is a heavy-atom derivative crystal.

### Claim 16 (depends on 14)

The crystalline protein, sub unit, or co-complex of claim 14, in which PAK4KD protein is a mutant.

### Claim 17 (depends on 16)

The crystalline protein, sub unit, or co-complex of claim 16, which is characterized by a set of structural coordinates that is substantially similar to the set of structural coordinates of FIGS. 4-10.

### Claim 18 (depends on 14)

A machine-readable medium embedded with information that corresponds to a three-dimensional structural representation of a crystal of claim 14.

### Claim 19

A machine-readable medium embedded with the molecular structural coordinates of FIGS. 4-10, or at least 50% of the coordinates thereof.

### Claim 20

A machine-readable medium embedded with the molecular structural coordinates of a protein molecule comprising a PAK4KD protein binding pocket, wherein said binding pocket comprises at least three amino acids selected from the group consisting of Val158, Met218, Leu270, Glu219, Leu221, Asp281, Val216, Met193, and Phe282 having the structural coordinates of FIGS. 4-10, or by the structural coordinates of a binding pocket homolog, wherein said the root mean square deviation of the backbone atoms of the amino acid residues of said binding pocket and said binding pocket homolog is less than 2.0 Å.

### Claim 21

A method for determining whether a compound binds PAK4KD protein, comprising,
a) providing a computer modeling program with a set of structural coordinates or a three dimensional conformation for a molecule that comprises a binding pocket of PAK4KD protein, or a homolog thereof;
b) providing a said computer modeling program with a set of structural coordinates of a chemical entity;
c) using said computer modeling program to evaluate the potential binding or interfering interactions between the chemical entity and said binding pocket; and
d) determining whether said chemical entity potentially binds to or interferes with said protein or homolog.
